Filament Health Corp.
FH
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.15% | -67.38% | -89.33% | -94.48% | 72.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.15% | -67.38% | -89.33% | -94.48% | 72.47% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 40.15% | -67.38% | -89.33% | -94.48% | 72.47% |
| SG&A Expenses | -42.70% | -25.40% | -40.71% | -41.04% | -33.99% |
| Depreciation & Amortization | -1.28% | -5.06% | -1.02% | -0.75% | 2.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.91% | -21.16% | -45.77% | -38.98% | -29.12% |
| Operating Income | 53.17% | 0.82% | -31.17% | 22.09% | 33.92% |
| Income Before Tax | 44.97% | 12.29% | -61.76% | 26.70% | 33.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.13% | 12.29% | -61.76% | 26.70% | 33.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.13% | 12.29% | -61.76% | 26.70% | 33.51% |
| EBIT | 53.17% | 0.82% | -31.17% | 22.09% | 33.92% |
| EBITDA | 52.47% | -4.67% | -31.77% | 20.00% | 35.38% |
| EPS Basic | 52.94% | 28.13% | -40.00% | 50.00% | 47.69% |
| Normalized Basic EPS | 52.38% | 30.00% | 8.00% | 51.43% | 48.78% |
| EPS Diluted | 52.94% | 28.13% | -40.00% | 50.00% | 47.69% |
| Normalized Diluted EPS | 52.38% | 30.00% | 8.00% | 51.43% | 48.78% |
| Average Basic Shares Outstanding | 18.94% | 23.95% | 15.87% | 46.44% | 25.81% |
| Average Diluted Shares Outstanding | 18.94% | 23.95% | 15.87% | 46.44% | 25.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |